NTRR Develops New Advanced Prototype for Cannabis Testing
Neutra Corp. (OTCBB: NTRR), a growing provider of all-natural wellness solutions, announced today that development is currently underway on a new advanced prototype of the company’s innovative, disposable cannabis testing strips.
Led by Dr. Richard C. Kaufman, the company’s new head of research and development in the $42 billion nutraceuticals industry, NTRR is developing a disposable system for testing oils, butters, tinctures, resins and other concentrates derived from medical marijuana (MMJ) for potentially harmful contaminants. As the use and regulation of MMJ continues to spread across the country, demand for simple, reliable testing for molds, fungi and chemicals is exploding from state agencies, dispensaries and patients alike.
Early last month, NTRR signed a laboratory agreement to begin analyzing the effectiveness of its new test strips. Now, the company is forging ahead with a new prototype system that improves upon the efficacy and efficiency of the original design.
If successful, the innovative system could help NTRR capture a big share of an MMJ testing market poised for unprecedented growth as more and more states sign MMJ laws.
“We’re excited to offer MMJ patients a closer, more detailed look at what they’re consuming,” said NTRR CEO Sydney Jim.
By providing innovative nutraceutical products and services, Neutra Corp. plans to compete for customers with other successful public companies including Cannabis Science, Inc. (OTCBB: CBIS), Medical Marijuana Inc. (OTCBB: MJNA) and Terra Tech Corp. (OTCBB: TRTC), delivering technological advancements in the cultivation and processing of cannabis in approved markets.
For more information on NTRR’s initiatives, please visit www.neutracorp.com.
About Neutra Corp.
Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. For investing information and performance data, please visit www.neutracorp.com.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.
Neutra Corp.
Sydney Jim, 813-367-2041
President and CEO
info@neutracorp.com
Neutra Corp. (OTCBB: NTRR), a growing provider of all-natural wellness solutions, announced today that development is currently underway on a new advanced prototype of the company’s innovative, disposable cannabis testing strips.
Led by Dr. Richard C. Kaufman, the company’s new head of research and development in the $42 billion nutraceuticals industry, NTRR is developing a disposable system for testing oils, butters, tinctures, resins and other concentrates derived from medical marijuana (MMJ) for potentially harmful contaminants. As the use and regulation of MMJ continues to spread across the country, demand for simple, reliable testing for molds, fungi and chemicals is exploding from state agencies, dispensaries and patients alike.
Early last month, NTRR signed a laboratory agreement to begin analyzing the effectiveness of its new test strips. Now, the company is forging ahead with a new prototype system that improves upon the efficacy and efficiency of the original design.
If successful, the innovative system could help NTRR capture a big share of an MMJ testing market poised for unprecedented growth as more and more states sign MMJ laws.
“We’re excited to offer MMJ patients a closer, more detailed look at what they’re consuming,” said NTRR CEO Sydney Jim.
By providing innovative nutraceutical products and services, Neutra Corp. plans to compete for customers with other successful public companies including Cannabis Science, Inc. (OTCBB: CBIS), Medical Marijuana Inc. (OTCBB: MJNA) and Terra Tech Corp. (OTCBB: TRTC), delivering technological advancements in the cultivation and processing of cannabis in approved markets.
For more information on NTRR’s initiatives, please visit www.neutracorp.com.
About Neutra Corp.
Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. For investing information and performance data, please visit www.neutracorp.com.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.
Neutra Corp.
Sydney Jim, 813-367-2041
President and CEO
info@neutracorp.com
